118262-90-1

Basic information

• Product Name: 7-(trifluoromethyl)-1,3,4,5-tetrahydro-3-hydroxy-3-(methoxycarbonyl)-4-(4-methoxyphenyl)-2H-1-benzazepin-2-one
• Synonyms: 7-(trifluoromethyl)-1,3,4,5-tetrahydro-3-hydroxy-3-(methoxycarbonyl)-4-(4-methoxyphenyl)-2H-1-benzazepin-2-one
• CAS NO: 118262-90-1
• Molecular Weight: 409.362
• Mol File: 118262-90-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 7-(trifluoromethyl)-1,3,4,5-tetrahydro-3-hydroxy-3-(methoxycarbonyl)-4-(4-methoxyphenyl)-2H-1-benzazepin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 7-(trifluoromethyl)-1,3,4,5-tetrahydro-3-hydroxy-3-(methoxycarbonyl)-4-(4-methoxyphenyl)-2H-1-benzazepin-2-one(118262-90-1)
• EPA Substance Registry System: 7-(trifluoromethyl)-1,3,4,5-tetrahydro-3-hydroxy-3-(methoxycarbonyl)-4-(4-methoxyphenyl)-2H-1-benzazepin-2-one(118262-90-1)

Safety Data

• Hazardous Substances Data: 118262-90-1(Hazardous Substances Data)

Upstream product

• 111604-85-4 [2-(5-trifluoromethyl-2-nitrophenyl)-1-(4-methoxyphenyl)ethyl]propanedioic acid,dimethyl ester 
• 111604-90-1 [2-(5-trifluoromethyl-2-aminophenyl)-1-(4-methoxyphenyl)ethyl]propanedioic acid,dimethyl ester 
• 7443-25-6 dimethyl 2-(4-methoxybenzylidene)malonate 
• 67192-42-1 2-methyl-4-trifluoromethylnitrobenzene 
• 111604-91-2 (3R,4S)-4-(4-Methoxy-phenyl)-2-oxo-7-trifluoromethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine-3-carboxylic acid methyl ester 

Downstream Products

• 138337-25-4 cis-3-hydroxy-1-<2-(dimethylamino)ethyl>-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-7-(trifluoromethyl)-2H-1-benzazepin-2-one 
• 138337-25-4 (3S,4R-cis)-3-hydroxy-1-<2-(dimethylamino)ethyl>-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-7-(trifluoromethyl)-2H-1-benzazepin-2-one 
• 138383-41-2 (cis)-3-(Hydroxy)-1-[2-(dimethylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-7-(trifluoromethyl)-2H-1-benzazepin-2-one 
• 138335-38-3 cis-1,3,4,5-tetrahydro-7-(trifluoromethyl)-3-(acetylthio)-1-<2-(dimethylamino)ethyl>-4-(4-methoxyphenyl)-2H-1-benzazepin-2-one 
• 138335-34-9 N-[(3S,4R)-1-(2-Dimethylamino-ethyl)-4-(4-methoxy-phenyl)-2-oxo-7-trifluoromethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl]-acetamide 
• 138335-18-9 Thioacetic acid S-[(3S,4R)-4-(4-methoxy-phenyl)-2-oxo-7-trifluoromethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl] ester 
• 138383-08-1 Acetic acid (3S,4R)-1-(2-dimethylamino-ethyl)-4-(4-methoxy-phenyl)-2-oxo-7-trifluoromethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl ester 
• 138335-10-1 (3S,4S)-3-Hydroxy-4-(4-methoxy-phenyl)-7-trifluoromethyl-1,3,4,5-tetrahydro-benzo[b]azepin-2-one 
• 118262-72-9 1,3,4,5-tetrahydro-7-(trifluoromethyl)-3-<(tolylsulfonyl)oxy>-4-(4-methoxyphenyl)-2H-1-benzazepin-2-one 
• 138335-08-7 (3R,4S)-3-Hydroxy-4-(4-methoxy-phenyl)-7-trifluoromethyl-1,3,4,5-tetrahydro-benzo[b]azepin-2-one 

Relevant articles and documents

Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site

We have synthesized a series of benzazepinones (2) in order to determine the structure-activity relationships (SAR) for calcium channel blockers related to diltiazem. A prerequisite for calcium channel blocking activity in vitro and in vivo is the presenc

Benzazepine derivatives

Vasodilating activity is exhibited by compounds having the formula STR1 and pharmaceutically acceptable salts thereof.